Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Sees Large Increase in Short Interest

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 100,700 shares, a growth of 15.5% from the November 15th total of 87,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Newron Pharmaceuticals Price Performance

Shares of NWPHF stock opened at $9.36 on Tuesday. Newron Pharmaceuticals has a 12-month low of $9.10 and a 12-month high of $12.00. The firm has a fifty day moving average of $9.36 and a 200-day moving average of $10.06.

About Newron Pharmaceuticals

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.